Kenyan Health Patient Information Leaflet
Fluoroquinolone antibiotic
Therapeutic use is agent- and indication-specific within the class (Fluoroquinolone antibiotic). Use according to culture results, national guidelines (Kenya STG/EML where applicable) and the current product SmPC.
Dosing is indication-, age-, weight- and organ-function-specific for this INN. Do not use class averages for high-risk patients. Confirm the exact regimen in the current SmPC and Kenya Standard Treatment Guidelines. Typical professional workflow: (1) confirm indication, (2) check renal/hepatic function, (3) screen interactions/allergies, (4) select dose/route/duration, (5) define monitoring.
GI upset, headache, dizziness, insomnia. Serious: tendon rupture, neuropathy, seizures, QT prolongation/TdP, severe hypersensitivity, C. difficile, aortic events (rare), dysglycaemia.
Store as labelled. Keep out of reach of children.